Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
PHARMA RUE NEUVE from Brussel, company number BE0704609285, closed financial year 2025 with a result of € 0 after tax. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 12,400
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 12,400
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Equity | € 12,400 | € 12,400 | € 12,400 | € 12,400 | |
| Cash | € 12,400 | € 12,400 | € 12,400 | € 12,400 | |
| Balance sheet total | € 12,400 | € 12,400 | € 12,400 | € 12,400 |
Key figures of PHARMA RUE NEUVE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMA RUE NEUVE?
What happened at PHARMA RUE NEUVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. filed late Source: NBB ↗
- Boubker TAMOURO became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 0 profit in 2022 to € 0 profit in 2025.
A new publication or filing at PHARMA RUE NEUVE? We notify you, reason included.
Follow PHARMA RUE NEUVEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMA RUE NEUVE is Boubker TAMOURO. Boubker TAMOURO is also behind SARDAPHARMA.
Directors
According to the 2025 annual accounts
since 2018
Establishments
Establishment units
Physical locations of this company
Finisterraestraat 24
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0704.609.285
- VAT number
- BE 0704.609.285
- Registered office
- Finisterraestraat 24, 1000 Brussel
- Names & denominations
- PHARMA RUE NEUVE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 September 2018
- Peppol
- Not registered